Few Global Players Dominate the Market despite the Presence of about ~100 Competitors Comprising a Large Number of Regional Players and Some Specialist Players, finds a recent market study on the Global 3D Bioprinting Market by Ken Research
3D bioprinting is a technology where bioinks, mixed with living cells, are printed in 3D to construct natural tissue-like three-dimensional structures. This technology can be used in various research areas, such as tissue engineering and new drug development.
Ken Research shares 3 key insights on the competitive landscape of this dynamic market from its latest research study.
Request For Sample Report @https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MTY4
Global Players Constitute ~30% of the Total Number of Competitors, While Regional Players Dominate Representing ~45% of Total Competitors.
A comprehensive competitive analysis conducted during the Research Study found that the global 3D Bioprinting Market is competitive with ~100 players, including globally diversified players, regional players, and many country-niche players. The regional players comprise about ~45% in terms of the number of companies followed by global players with ~30% of the total competitors.
High Demand for Tissues and Organs for Transplantation is expected to be the Primary Driver of the Market.
Detailed comparative analysis of key competitors available within the Research Study shows that major players such as Inventia Life Science, Poietis, VIVAX BIO, LLC, CYFUSE BIOMEDICAL K.K., 3D Bioprinting Solutions, and others are highly focused on developing 3D bioprinting technologies that can be used across resaerch institutes and clinics. Furthermore, several companies and organizations are aggressively focusing on acquisitions and mergers with specialized players to invest in 3D Bioprintingproducts.
- In November 2021, 3D Systems Corp., a pioneering 3D bioprinting company acquired Volumetric, one of the top startups in this niche segment. With the acquisition, the group plans to establish a world-class research capability in Houston, Texas, one of the leading life sciences regions in the world.
- In June 2021, CollPlant Biotechnologies Ltd and 3D Systems, Inc. signed a co-development agreement for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant.
Several Government Initiatives, Increased Partnerships and New Strategical Investments Led to Major Industry-Wide Developments and Acquisitions, in the industry.
- In August 2022, The Indian Institute of Science partnered with Sweden-based Cellink, a global leader in developing 3D bioprinters, to set up a centre of excellence (CoE) for 3D bioprinting in India.
In May 2022, the administration of the USA president launched the AM Forward program, meant to further spur the growth of additive manufacturing (AM) in the country. The program will see the USA government and giant multinationals support 3D printing initiatives, small-and-medium sized enterprises (SMEs) in various ways.
Request For Sample Report @https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MTY4
Key Topics Covered in the Report
- Snapshot of Global 3D Bioprinting Market
- Industry Value Chain and Ecosystem Analysis
- Market size and Segmentation of the Global 3D Bioprinting Market
- Historic Growth of Overall Global 3D Bioprinting Market and Segments
- Competition Scenario of the Market and Key Developments of Competitors
- Porter’s 5 Forces Analysis of Global 3D Bioprinting Industry
- Overview, Product Offerings, Strengths, & Weaknesses of Key Competitors
- Covid-19 Impact on the Overall Global 3D Bioprinting Market
- Future Market Forecast and Growth Rates of the Global 3D Bioprinting Market and Segments
- Analysis of Global 3D Bioprinting Market
- Major Production/Supply and Consumption/Demand Hubs within Each Region
- Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments
- Overview of Notable Emerging Competitor Companies within Each Region
Notable Key Players Mentioned in the Report
- Organovo Holdings, Inc.
- Inventia Life Science
- Poietis
- VIVAX BIO, LLC
- CYFUSE BIOMEDICAL K.K.
- 3D Bioprinting Solutions
- CELLINK
- BICO - THE BIO CONVERGENCE COMPANY
- CollPlant Biotechnologies Ltd.
- Aspect Biosystems Ltd.
Notable Emerging Companies Mentioned in the Report
- Organovo
- Prellis Biologics
- Pandorum Technologies
- Regenovo Biotechnology
Key Target Audience – Organizations and Entities Who Can Benefit by Subscribing This Report
- 3D Bioprinting Manufacturers
- 3D Bioprinting Suppliers
- 3D Bioprinters Manufacturers
- Bioinks Manufacturers
- Living Cells Suppliers
- Hydrogels Suppliers
- Extracellular Matrices Suppliers
- 3D Bioprinting Distributors
- Emerging and Startup Companies in 3D Bioprinting
- Different Types of 3D Bioprinting Manufacturing Hubs
- Government Departments of Healthcare
- Government Departments of Pharmaceuticals
- Ministries and Departments of Bio-based Materials
- Importers and Distributors of 3D Bioprinting
Period Captured in the Report
- Historical Period: 2017-2021
- Forecast Period: 2022E-2028F
For more insights on the market intelligence, refer to the link below: –
Global 3D Bioprinting Market: Ken Research
Follow Us –
